Alto Neuroscience ANRO
NYSE ANRO
$35.56 -0.84 (-2.31%)
As of: Sep 4, 2026 · 3:59 PM EDT

Alto Neuroscience (ANRO) Interest & Investment Income (2023 - 2026)

Alto Neuroscience (ANRO) posted Interest & Investment Income of $1.6 million for Q1 2026, little changed sequentially from $1.6 million in Q4 2025, and down 14.56% YoY from $1.8 million in Q1 2025.

Analysis

Alto Neuroscience (ANRO) Interest & Investment Income (2023 - 2026) Analysis & Trends

Alto Neuroscience has reported Interest & Investment Income for 4 years, with the latest figure at $1.6 million in Q1 2026.

  • Quarterly Interest & Investment Income fell 14.56% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.3 million (down 30.52% YoY) and the FY2025 annual result came in at $6.6 million, down 25.4% from the prior year.
  • Interest & Investment Income was little changed at $1.6 million in Q1 2026 per ANRO's latest filing, from $1.6 million in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $2.7 million in Q2 2024 and troughed at $230000.0 in Q1 2023.
  • A 4-year average of $1.5 million and a median of $1.6 million in 2025 frame the typical range for Interest & Investment Income.
  • The sharpest annual moves came in 2024 and 2025: Interest & Investment Income soared 577.39% in 2024, then sank 38.72% in 2025.
  • Over 4 years, Interest & Investment Income stood at $738000.0 in 2023, then surged by 189.3% to $2.1 million in 2024, then slipped by 26.89% to $1.6 million in 2025, then changed by 0.0% to $1.6 million in 2026.
  • According to Business Quant data, Interest & Investment Income over the past three periods registered $1.6 million, $1.6 million, and $1.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 48.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 67.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 35.58 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 27.90 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 28.14 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 5.13 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 10.98 Mn
10 Alto Neuroscience 1.52 Bn 1.52 Bn - 2.11 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.11 Mn
Mar 31, 2026 1.56 Mn
Dec 31, 2025 1.56 Mn
Sep 30, 2025 1.53 Mn
Jun 30, 2025 1.68 Mn
Mar 31, 2025 1.83 Mn
Dec 31, 2024 2.14 Mn
Sep 30, 2024 2.50 Mn
Jun 30, 2024 2.66 Mn
Mar 31, 2024 1.56 Mn
Dec 31, 2023 738,000.00
Sep 30, 2023 714,000.00
Jun 30, 2023 667,000.00
Mar 31, 2023 230,000.00